Literature DB >> 11801514

Evaluation of corneal graft rejection in a mouse model.

J Plsková1, L Kuffová, V Holán, M Filipec, J V Forrester.   

Abstract

Corneal graft rejection presents clinically and in experimental models as opacification and is considered to be the result of endothelial cell dysfunction or loss. However, recovery from opacification can occur suggesting either (a) that new endothelial cells can regenerate if the original cells were lost, or (b) that sufficient numbers of original cells can regain function if the opacification was due to temporary dysfunction. In this perspective, previous experimental studies of allograft rejection plus some new data are reviewed to support the latter mechanism.

Entities:  

Mesh:

Year:  2002        PMID: 11801514      PMCID: PMC1770977          DOI: 10.1136/bjo.86.1.108

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  32 in total

1.  CD4+ T cells are critical for corneal, but not skin, allograft rejection.

Authors:  Z Haskova; N Usiu; J S Pepose; T A Ferguson; P M Stuart
Journal:  Transplantation       Date:  2000-02-27       Impact factor: 4.939

2.  Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection.

Authors:  D F Larkin; V L Calder; S L Lightman
Journal:  Clin Exp Immunol       Date:  1997-02       Impact factor: 4.330

Review 3.  Rethinking immunological privilege: implications for corneal and limbal stem cell transplantation.

Authors:  K A Williams; D J Coster
Journal:  Mol Med Today       Date:  1997-11

4.  Anterior chamber-associated immune deviation promotes corneal allograft survival.

Authors:  J Y Niederkorn; J Mellon
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-12       Impact factor: 4.799

5.  CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.

Authors:  P M Stuart; T S Griffith; N Usui; J Pepose; X Yu; T A Ferguson
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

6.  The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.

Authors:  Z Hasková; M Filipec; V Holán
Journal:  Folia Biol (Praha)       Date:  1996       Impact factor: 0.906

7.  A new model of orthotopic penetrating corneal transplantation in the sheep: graft survival, phenotypes of graft-infiltrating cells and local cytokine production.

Authors:  K A Williams; S D Standfield; R A Mills; T Takano; D F Larkin; R Krishnan; G R Russ; D J Coster
Journal:  Aust N Z J Ophthalmol       Date:  1999-04

8.  Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model.

Authors:  A Reis; T Reinhard; R Sundmacher; C Braunstein; E Godehardt
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

9.  Fate of orthotopic corneal allografts in C57BL/6 mice.

Authors:  J Yamada; J W Streilein
Journal:  Transpl Immunol       Date:  1998-09       Impact factor: 1.708

10.  Heterotopic corneal grafting in mice: a new approach to the study of corneal alloimmunity.

Authors:  J W Streilein; J McCulley; J Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-10       Impact factor: 4.799

View more
  17 in total

1.  Corneal opacification following keratoplasty in the rat model.

Authors:  Ilse Claerhout
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.

Authors:  Yang Kyung Cho; Hironori Uehara; Jason R Young; Puneet Tyagi; Uday B Kompella; Xiaohui Zhang; Ling Luo; Nirbhai Singh; Bonnie Archer; Balamurali K Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-30       Impact factor: 4.799

3.  Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Authors:  Alexander M Rowe; Hongming Yun; Benjamin R Treat; Paul R Kinchington; Robert L Hendricks
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

4.  Regeneration of corneal endothelium following complete endothelial cell loss in rat keratoplasty.

Authors:  J Schwartzkopff; L Bredow; S Mahlenbrey; D Boehringer; T Reinhard
Journal:  Mol Vis       Date:  2010-11-11       Impact factor: 2.367

5.  Quantitative evaluation of the corneal endothelium in the mouse after grafting.

Authors:  J Plskova; L Kuffova; M Filipec; V Holan; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

6.  Evaluation of corneal graft survival in mice model.

Authors:  Guo-Ling Chen; Jing-Jing Zhang; Jun Zhao; Da-Jiang Wang; Han Zhang
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

7.  Prevention of corneal allograft rejection in a mouse model of high risk recipients.

Authors:  A Vítová; M Filipec; A Zajícová; M Krulová; V Holán
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 8.  Angiogenesis and lymphangiogenesis in corneal transplantation-A review.

Authors:  Wei Zhong; Mario Montana; Samuel M Santosa; Irene D Isjwara; Yu-Hui Huang; Kyu-Yeon Han; Christopher O'Neil; Ashley Wang; Maria Soledad Cortina; Jose de la Cruz; Qiang Zhou; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2017-12-27       Impact factor: 6.048

9.  Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.

Authors:  Chyan-Jang Lee; Oleksiy Buznyk; Lucia Kuffova; Vijayalakshmi Rajendran; John V Forrester; Jaywant Phopase; Mohammad M Islam; Mårten Skog; Jenny Ahlqvist; May Griffith
Journal:  Transl Vis Sci Technol       Date:  2014-05-29       Impact factor: 3.283

10.  Lymph node removal enhances corneal graft survival in mice at high risk of rejection.

Authors:  Jarmila Plsková; Vladimír Holán; Martin Filipec; John V Forrester
Journal:  BMC Ophthalmol       Date:  2004-03-23       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.